AHP1279B is specific for human CXCL5, otherwise known as ENA-78, (epithelial-derived neutrophil-activating protein 78), a CXC chemokine expressed by monocytes, mast cells, platelets, eosinophils and endothelial cells, which acts as a key modulator of the inflammatory response, but also exhibits angiogenic properties, including tumour progression.
CXCL5 signals through binding to CXC receptor 2 (CXCR2) and occurs naturally in three isoforms: ENA 5-78 (74 amino acids), ENA 9-78 (70 amino acids) and ENA 10-78 (69 amino acids).
Application
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visitwww.abdserotec.com/protocols.
Application Name
Yes
No
Not Determined
Suggested Dilution
ELISA
0.25 - 1.0ug/ml
Flow Cytometry
Immunohistology - Frozen
Immunohistology - Paraffin
Immunoprecipitation
Western Blotting
0.1 - 0.2ug/ml
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Storage
Prior to reconstitution store at +4oC.
After reconstitution store at -20oC.
Storage in frost-free freezers is not recommended. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Shelf Life
12 months from date of reconstitution.
Antiserum Preparation
Antisera to human CXCL5 were raised by repeated immunisations of rabbits with highly purified antigen. Purified IgG was prepared from whole serum by affinity chromatography.